Hematology & Oncology Doctors in Middletown, CT Accepting Medicare
7 Hematology & Oncology doctors found. Showing 1 - 7
 Dr. Miklos C. Fogarasi, M.D. Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 |
Dr. James E Brown, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 |
Dr. Mark Kimmel, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 |
Dr. Robert J. Levy, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 |
 Dr. Elizabeth Ann Mariano, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2223 |
Dr. Susanna Hong, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 |
Dr. Michael P. Farrell, M.D., PH.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 |
News Archive
Anti-phospholipid antibodies in severely ill patients not distinctive to COVID-19, says study
A new study by researchers at the University of Toronto and the University of Calgary in Canada indicates that the presence of these antibodies correlates with more severe COVID-19 symptoms and signs.
JAK-STAT inhibitors reverse MS-like disease in mice
A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.
Ambrisentan improves health and exercise capacity of PAH patients, find researchers
In one of the few studies of the long-term effects of medication in the treatment of pulmonary arterial hypertension (PAH) disease, a team of researchers found the health and exercise capacity of PAH patients improved after two years of treatment with ambrisentan, according to a study published in the current edition of the Journal of the American College of Cardiology.
Scientists create 'all-atom' model of SARS-CoV-2 spike protein
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease (COVID-19), an illness that has spread across the globe, infecting more than 9 million people. The novel coronavirus invades cells through "spike proteins," which sticks and binds itself to a host cell.
Health Canada warns Canadians against illegal health products
A vendor in Atlantic Canada (www.health-recovery-info.com) is selling Miracle Mineral Solution (MMS), an unauthorized drug product which Health Canada has previously warned may pose serious risks to health if ingested.
› Verified 1 days ago
Psychiatry & Neurology
Internal Medicine
Family Medicine
Emergency Medicine
Radiology
Anesthesiology
Orthopaedic Surgery
Obstetrics & Gynecology
Pediatrics
Surgery
Hospitalist